-
Mashup Score: 0Real-World Study Examines Genomic Profiling Challenges for Patients With Cancers of Unknown Primary - 2 year(s) ago
The researchers found that more than half of patients with CUP did not have sufficient tissue to undergo genomic profiling.
Source: Precision Medicine OnlineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 8Grieving in a Pandemic | NEJM - 3 year(s) ago
Perspective from The New England Journal of Medicine — Grieving in a Pandemic
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Well-stated reflection about grief: “Suffering my own loss helped me to understand how much of grief is about losing our idea of the future.” @NEJM https://t.co/blBIMQrfpt
-
-
Mashup Score: 1No Good Treatment Options, So I’ll Eat Ice Cream - The ASCO Post - 3 year(s) ago
On a warm summer afternoon, I stood in front of tables at the local farmers market loaded with my favorite fruits and vegetables: peaches, tomatoes, corn, peppers, melons, kale. I practically drooled thinking about what I could make that week: corn and tomato salad, kale and mushroom quesadillas, chilled melon soup. The…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Well-written on the nuances and struggles many face. And I’m very pro-ice cream. // No Good Treatment Options, So I’ll Eat Ice Cream - The ASCO Post https://t.co/WOsPwrr1aQ
-
-
Mashup Score: 1035Does My Son Know You? - 3 year(s) ago
Fatherhood, cancer, and what matters most
Source: The RingerCategories: Latest Headlines, Oncologists1Tweet-
RT @JonathanTjarks: Does My Son Know You? https://t.co/37lKB9pGgJ via @ringer
-
-
Mashup Score: 0
Jonathan Sanford left the Spurs to move to Houston so his wife could be closer to MD…
Source: Houston ChronicleCategories: Hem/Oncs, Latest HeadlinesTweet-
Today’s feel-good story involves two of my favorite things, the @NBA and @MDAndersonNews: https://t.co/ELq8mUeNoE
-
-
Mashup Score: 0
Perspective from The New England Journal of Medicine — Research Participation in Marginalized Communities — Overcoming Barriers
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Good piece in @NEJM discussing barriers for marginalized populations to participate in clinical research. Important for knowledge generation and applicability to diverse populations https://t.co/wMFjkGz9pM
-
-
Mashup Score: 0Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers - Full Text View - ClinicalTrials.gov - 3 year(s) ago
Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers – Full Text View.
Source: clinicaltrials.govCategories: Latest Headlines, Oncologists1Tweet-
Important space with important ongoing work, including by @michael_overman with NCT04082572 https://t.co/0nvMRGiEpn
-
-
Mashup Score: 0Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Gastric Cancer - 3 year(s) ago
This phase 3, randomized, controlled, partially blinded interventional study evaluates the antitumor activity of pembrolizumab, pembrolizumab plus chemotherapy, or chemotherapy alone in patients with untreated, advanced gastric/gastroesophageal junction cancer with PD-L1 combined positive score ≥1.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Overall, longer term follow-up data looks consistent with initial analysis: https://t.co/tVLf5cdLYt #GI22
-
Thanks to Precision Medicine Online for writing it up: https://t.co/jf6EyJRIrM https://t.co/qaaOBPPfV5